Literature DB >> 10674730

Frontalis suspension combined with blepharoplasty as an effective treatment for blepharospasm associated with apraxia of eyelid opening.

V De Groot1, F De Wilde, L Smet, M J Tassignon.   

Abstract

PURPOSE: Essential blepharospasm can be associated with apraxia of eyelid opening and is characterized by the inability to initiate the act of eyelid elevation even after cessation of orbicularis spasms. Current therapies such as botulinum toxin injections, orbicularis resection, or neurectomy may be unsuccessful or have undesired side effects.
METHODS: Frontalis suspension was used to treat 13 consecutive patients with apraxia and blepharospasm during a 4-year interval. Follow-up ranged from 16 months to 55 months. To improve the aesthetic outcome, an upper blepharoplasty was done at the same time as the frontalis suspension in 7 cases.
RESULTS: Good or excellent functional results were obtained in 10 of 13 patients. In 6 of these patients, the spasm disappeared completely. Therapy was unsuccessful in 1 patient, and in 2 patients blepharospasm recurred after 9 months.
CONCLUSION: Patients with blepharospasm and apraxia of eyelid opening may benefit from a frontalis suspension operation, which can be considered minimally invasive and reversible.

Entities:  

Mesh:

Year:  2000        PMID: 10674730     DOI: 10.1097/00002341-200001000-00006

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.

Authors:  Bettina Wabbels; Peter Roggenkämper
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-28       Impact factor: 3.117

2.  Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.

Authors:  Jeremy Clark; John Randolph; Jason A Sokol; Nicholas A Moore; Hui Bae H Lee; William R Nunery
Journal:  Digit J Ophthalmol       Date:  2017-11-05

3.  SURGICAL ASPECT OF BLEPHAROSPASM TREATMENT: A CASE REPORT.

Authors:  Kristijan Dinjar; Vedran Zubčić; Andrijana Kopić; Vlatko Kopić; Bruno Popić; Dubravka Holik
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

Review 4.  Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.

Authors:  Ali G Hamedani; Daniel R Gold
Journal:  Front Neurol       Date:  2017-07-18       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.